date,title,source
Oct-18-18,"Recent Analysis Shows Lantheus, Editas Medicine, CorMedix, DXP Enterprises, Peabody Energy, and CommScope Holding Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Oct-26-18,Editas Medicine (EDIT) Stock Moves -0.95%: What You Should Know,Zacks
Oct-31-18,Editas Medicine to Host Conference Call Discussing Third Quarter 2018 Corporate Update and Results,GlobeNewswire
Oct-31-18,Is a Beat in Store for Editas (EDIT) This Earnings Season?,Zacks
Nov-05-18,Here's Why CRISPR Stocks Fell as Much as 40.7% in October,Motley Fool
Nov-05-18,5 Drug/Biotech Stocks Set to Trump Estimates in Q3 Earnings,Zacks
Nov-07-18,Cambridge's Editas asks FDA to start gene editing trial,American City Business Journals
Nov-07-18,"Editas Medicine, Inc. (EDIT) Q3 2018 Earnings Conference Call Transcript",Motley Fool
Nov-07-18,"Editas Medicine (EDIT) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-07-18,Editas: 3Q Earnings Snapshot,Associated Press
Nov-07-18,Editas Medicine Announces Third Quarter 2018 Results and Update,GlobeNewswire
Nov-08-18,Editas Medicine Makes Steady Progress in Another Solid Quarter,Motley Fool
Nov-12-18,"Analysis: Positioning to Benefit within IDEXX Laboratories, Editas Medicine, Arconic, Cardtronics, Cloudera, and BMC Stock  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Nov-26-18,Mass. biotech leaders voice alarm over report of first gene-edited babies,American City Business Journals
Nov-30-18,This Biotech Stock Could Launch Its First CRISPR Drug In 2022,Investor's Business Daily
Nov-30-18,Why Crispr Therapeutics Stock Is Up By 65% So Far in 2018,Motley Fool
Nov-30-18,FDA clears Editas to test gene-editing drug in humans,American City Business Journals
Nov-30-18,Editas Medicine Announces FDA Acceptance of IND Application for EDIT-101,GlobeNewswire
Dec-10-18,Here's Why Editas Medicine Jumped 23% in November,Motley Fool
Dec-10-18,Editas Medicine Names Cynthia Collins to Board of Directors,GlobeNewswire
Dec-13-18,Edited Transcript of EDIT earnings conference call or presentation 7-Nov-18 10:00pm GMT,Thomson Reuters StreetEvents
Dec-21-18,"Why Perrigo, New Age Beverages, and Editas Medicine Slumped Today",Motley Fool
Dec-21-18,Why Editas Medicine Is Sinking Today,Motley Fool
Dec-21-18,Editas Medicine Announces Transition of Chief Financial Officer,GlobeNewswire
Dec-28-18,Horizon Pharma's Ravicti Gets FDA Nod for Expanded Age Group,Zacks
Jan-02-19,Editas Medicine to Present at the 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Jan-03-19,Novo Nordisk Boasts Strong Diabetes Presence and Pipeline,Zacks
Jan-03-19,2019 Starts Off in the Green,Zacks
Jan-03-19,Sarepta (SRPT) Inks Deal With Aldevron for Plasmid DNA Supply,Zacks
Jan-04-19,Jazz Inks Deal with Codiak to Develop Exosome Therapeutics,Zacks
Jan-04-19,These Stocks Pop After FDA Expedites Review Of Gene-Editing Therapy,Investor's Business Daily
Jan-07-19,Aerie's Rhopressa Succeeds in Study on Japanese Patients,Zacks
Jan-07-19,"Vertex, CRISPR's Sickle Disease Drug Gets FDA's Fast Track Tag",Zacks
Jan-07-19,Editas Medicine Reports on Recent Progress at J.P. Morgan Healthcare Conference,GlobeNewswire
Jan-08-19,Editas CEO Katrine Bosley: We take the responsibility of ...,CNBC Videos
Jan-08-19,"Radius Exceeds 2018 Financial Guidance, Provides Updates",Zacks
Jan-08-19,Alnylam (ALNY) Reports Preliminary Onpattro Revenues for Q4,Zacks
Jan-08-19,Has Editas Medicine (EDIT) Outpaced Other Medical Stocks This Year?,Zacks
Jan-08-19,"Editas Medicine, YY, Intel, Advanced Micro Devices and NVIDIA highlighted as Zacks Bull and Bear of the Day",Zacks
Jan-08-19,Bull of the Day: Editas Medicine (EDIT),Zacks
Jan-09-19,CRISPR cadre: Check out the 12 Mass. companies exploring gene editing,American City Business Journals
Jan-10-19,Here's Why Editas Medicine Lost 16.6% in December,Motley Fool
Jan-10-19,"The Best CRISPR Stock Gained 21% in 2018, While The Worst Lost 29%",Motley Fool
Jan-10-19,4 Reasons Editas Medicine's Future Looks Really Bright,Motley Fool
Jan-11-19,Editas Medicine (EDIT) Dips More Than Broader Markets: What You Should Know,Zacks
Jan-15-19,Today's Research Reports on Trending Tickers: Exelixis and Editas Medicine,ACCESSWIRE
Jan-18-19,Editas Medicine (EDIT) Stock Sinks As Market Gains: What You Should Know,Zacks
Jan-18-19,4 Gene-Editing Technologies That Could Replace CRISPR,Motley Fool
Jan-22-19,Editas CEO Resigns  Sending All 3 CRISPR Stocks Into Free Fall,Investor's Business Daily
Jan-22-19,Why Editas Medicine Is Crashing Today,Motley Fool
Jan-22-19,Editas stock down 21% after announcing CEO departure,MarketWatch
Jan-22-19,"Gene-Editing Stocks Plunge on Editas CEO Exit, Crispr Downgrade",Bloomberg
Jan-22-19,Editas CEO to step down amid management turnover at gene-editing firm,American City Business Journals
Jan-22-19,Editas Medicine Announces Chief Executive Officer Transition,GlobeNewswire
Jan-23-19,Better Buy: CRISPR Therapeutics vs. Editas Medicine,Motley Fool
Jan-23-19,Today's Research Reports on Trending Tickers: Editas Medicine and argenx,ACCESSWIRE
Jan-24-19,"Market Trends Toward New Normal in SeaWorld Entertainment, Rigel Pharmaceuticals, Guidewire Software, Editas Medicine, Jones Energy, and Rexahn Pharmaceuticals  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Jan-25-19,Editas Medicine (EDIT) Gains But Lags Market: What You Should Know,Zacks
Jan-30-19,"How Many Insiders Bought Editas Medicine, Inc. (NASDAQ:EDIT) Shares?",Simply Wall St.
Feb-01-19,Editas Medicine (EDIT) Stock Sinks As Market Gains: What You Should Know,Zacks
Feb-01-19,3 Biotech Stocks That Are Set for a Breakthrough,InvestorPlace
Feb-06-19,"Editas Medicine Names David Scadden, M.D., to Board of Directors",GlobeNewswire
Feb-08-19,Editas Medicine (EDIT) Outpaces Stock Market Gains: What You Should Know,Zacks
Feb-14-19,Editas Medicine (EDIT) Dips More Than Broader Markets: What You Should Know,Zacks
Feb-14-19,Is Moderna a Buy?,Motley Fool
Feb-21-19,Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2018 Corporate Update and Results,GlobeNewswire
Feb-26-19,CRISPR Therapeutics Up as Dosing Starts in Thalassemia Study,Zacks
Feb-26-19,5 Gene Therapy Stocks to Enrich Your Portfolio,Zacks
Feb-27-19,"The Zacks Analyst Blog Highlights: Spark Therapeutics, Solid Biosciences, REGENXBIO, Editas Medicine and uniQure",Zacks
Feb-27-19,Editas (EDIT) to Report Q4 Earnings: What's in the Cards?,Zacks
Feb-28-19,Editas Medicine Announces Fourth Quarter and Full Year 2018 Results and Update,GlobeNewswire
Mar-01-19,Editas Medicine Prepares to Make History With EDIT-101,Motley Fool
Mar-04-19,Edited Transcript of EDIT earnings conference call or presentation 28-Feb-19 10:00pm GMT,Thomson Reuters StreetEvents
Mar-04-19,S&P Reclaims 2800; NASDAQs Streak Hits 10 Weeks,Zacks
Mar-07-19,5 Top Gene-Editing Stocks for 2019,Motley Fool
Mar-12-19,3 Stocks That Could Double Your Money,Motley Fool
Mar-18-19,"What Do Investors Need To Know About Editas Medicine, Inc.s (NASDAQ:EDIT) Earnings Outlook?",Simply Wall St.
Mar-21-19,"Should You Buy Bio-Path Stock After 5-Fold Gain? 3 Pros, 3 Cons",InvestorPlace
Mar-26-19,Better Buy: Editas Medicine vs. Sangamo Therapeutics,Motley Fool
Mar-26-19,"Research Report Identifies Spirit Airlines, Integrated Device Technology, Editas Medicine, MACOM Technology Solutions, Taylor Morrison Home, and Brunswick with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement",GlobeNewswire
